Copyright Reports & Markets. All rights reserved.

(Post-pandemic Era)-Global Genome Editing Market Segment Research Report 2022

Buy now

Table of Contents

    Global Genome Editing Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global Genome Editing Market by Value
          • 2.2.1 Global Genome Editing Revenue by Type
          • 2.2.2 Global Genome Editing Market by Value (%)
        • 2.3 Global Genome Editing Market by Production
          • 2.3.1 Global Genome Editing Production by Type
          • 2.3.2 Global Genome Editing Market by Production (%)

        3. The Major Driver of Genome Editing Industry

        • 3.1 Historical & Forecast Global Genome Editing Demand
        • 3.2 Largest Application for Genome Editing (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional Genome Editing Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of Genome Editing Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US Genome Editing Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe Genome Editing Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China Genome Editing Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan Genome Editing Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India Genome Editing Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea Genome Editing Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia Genome Editing Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global Genome Editing Average Price Trend

        • 12.1 Market Price for Each Type of Genome Editing in US (2018-2022)
        • 12.2 Market Price for Each Type of Genome Editing in Europe (2018-2022)
        • 12.3 Market Price for Each Type of Genome Editing in China (2018-2022)
        • 12.4 Market Price for Each Type of Genome Editing in Japan (2018-2022)
        • 12.5 Market Price for Each Type of Genome Editing in India (2018-2022)
        • 12.6 Market Price for Each Type of Genome Editing in Korea (2018-2022)
        • 12.7 Market Price for Each Type of Genome Editing in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 Genome Editing Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of Genome Editing

        14. Genome Editing Competitive Landscape

        • 14.1 Genscript
          • 14.1.1 Genscript Company Profiles
          • 14.1.2 Genscript Product Introduction
          • 14.1.3 Genscript Genome Editing Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 Horizon Discovery Group
          • 14.2.1 Horizon Discovery Group Company Profiles
          • 14.2.2 Horizon Discovery Group Product Introduction
          • 14.2.3 Horizon Discovery Group Genome Editing Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Lonza
          • 14.3.1 Lonza Company Profiles
          • 14.3.2 Lonza Product Introduction
          • 14.3.3 Lonza Genome Editing Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Merck KGaA
          • 14.4.1 Merck KGaA Company Profiles
          • 14.4.2 Merck KGaA Product Introduction
          • 14.4.3 Merck KGaA Genome Editing Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 Sangamo Therapeutics
          • 14.5.1 Sangamo Therapeutics Company Profiles
          • 14.5.2 Sangamo Therapeutics Product Introduction
          • 14.5.3 Sangamo Therapeutics Genome Editing Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Thermo Fisher Scientific
          • 14.6.1 Thermo Fisher Scientific Company Profiles
          • 14.6.2 Thermo Fisher Scientific Product Introduction
          • 14.6.3 Thermo Fisher Scientific Genome Editing Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives

        15. Conclusion

          16. Methodology and Data Source

          Summary

          The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

          2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

          According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

          Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Genome Editing Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Genome Editing industry at home and abroad, estimate the overall market scale of the Genome Editing industry and the market share of major countries, Genome Editing industry, and study and judge the downstream market demand of Genome Editing through systematic research, Analyze the competition pattern of Genome Editing, so as to help solve the pain points of various stakeholders in Genome Editing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

          Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Genome Editing Market by XYZResearch Include
          USA
          Europe
          China
          Japan
          India
          Korea
          Southeast Asia
          Competitive Analysis; Who are the Major Players in Genome Editing Market?
          Genscript
          Horizon Discovery Group
          Lonza
          Merck KGaA
          Sangamo Therapeutics
          Thermo Fisher Scientific
          Major Type of Genome Editing Covered in XYZResearch report:
          CRISPR
          TALEN
          ZFN
          Application Segments Covered in XYZResearch Market
          Cell Line Engineering
          Animal Genetic Engineering
          Plant Genetic Engineering

          For any other requirements, please feel free to contact us and we will provide you customized report.

          Buy now